Affimed's CEO Highlights Oncology Innovations at Leerink Conference Dr. Shawn Leland, CEO of Affimed, presented at the Leerink Partners Global Healthcare Conference on March 11, 2025. He discussed the company’s advancements in immuno-oncology and its proprietary platform for tumor-targeted therapies. The event was accessible via live webcast, with recordings available for 30 days.1